177 related articles for article (PubMed ID: 3111862)
1. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
Sármay G; Ramos OF; Klein E; Kai C; Gergely J
Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
[TBL] [Abstract][Full Text] [Related]
2. Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell lines.
Ramos OF; Sármay G; Eggertsen G; Nilsson B; Klein E; Gergely J
Eur J Immunol; 1987 Jul; 17(7):975-9. PubMed ID: 3111863
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
[TBL] [Abstract][Full Text] [Related]
4. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
5. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
Berger M; Fleisher TA
J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
[TBL] [Abstract][Full Text] [Related]
6. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
Praz F; Lesavre P
J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.
Schuurman RK; Gelfand EW; Dosch HM
J Immunol; 1980 Aug; 125(2):820-6. PubMed ID: 6967091
[TBL] [Abstract][Full Text] [Related]
8. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptors for IgA on mitogen-stimulated human T lymphocytes.
Millet I; Panaye G; Revillard JP
Eur J Immunol; 1988 Apr; 18(4):621-6. PubMed ID: 3259188
[TBL] [Abstract][Full Text] [Related]
10. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
Horwitz DA; Garrett MA
J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
[TBL] [Abstract][Full Text] [Related]
11. The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectors.
Ramos OF; Kai C; Yefenof E; Klein E
J Immunol; 1988 Feb; 140(4):1239-43. PubMed ID: 2963864
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies of Fc receptors for IgG on resting and activated mouse T lymphocytes using different methods].
Hückel C; Sandor M; Erdei A; Jensen HL; Brock J; Rychly J; Gergely J
Allerg Immunol (Leipz); 1986; 32(1):47-56. PubMed ID: 2940850
[TBL] [Abstract][Full Text] [Related]
13. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
[TBL] [Abstract][Full Text] [Related]
15. [Surface receptors on lymphocytes and blast cells developing from them after a 3-day culture stimulated with concanavalin A].
Pluzańska A
Acta Haematol Pol; 1976; 7(3):223-9. PubMed ID: 983670
[TBL] [Abstract][Full Text] [Related]
16. The third component of complement inhibits human lymphocyte blastogenesis.
Needleman BW; Weiler JM; Feldbush TL
J Immunol; 1981 Apr; 126(4):1586-91. PubMed ID: 7204978
[TBL] [Abstract][Full Text] [Related]
17. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
[TBL] [Abstract][Full Text] [Related]
18. Surface markers of complement receptor lymphocytes.
Ross GD; Winchester RJ; Rabellino EM; Hoffman T
J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
[TBL] [Abstract][Full Text] [Related]
19. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]